Showing results (271-280 of 317) with videos related to
Sort By:
Pageof 32
Discover Mental Health|November 5, 2024
Suicidal behavior in ADHD: the role of comorbidity, psychosocial adversity, personality and genetic factorsGeorg C Ziegler, Silke Groß, Andrea Boreatti, et al.Journal of Learning Disabilities|July 10, 2010
Support systems for poor readers: empirical data from six EU member statesElena Ise, Leo Blomert, Daisy Bertrand, et al.Memorias Do Instituto Oswaldo Cruz|September 5, 2006
Levels of complement C3 and C4 components in Amerindians living in an area with high prevalence of tuberculosisZaida Araujo, Nieves González, Laura de Cubeddu, et al.Bioconjugate Chemistry|September 30, 1999
RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imagingD S Edwards, S Liu, M C Ziegler, et al.Cancer Cell|May 18, 2004
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expressionChristine H Chung, Joel S Parker, Gamze Karaca, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 18, 2019
KCNJ6 variants modulate reward-related brain processes and impact executive functions in attention-deficit/hyperactivity disorderGeorg C Ziegler, Christoph Röser, Tobias Renner, et al.Breast Cancer Research and Treatment|June 21, 2007
Epidemiology of basal-like breast cancerRobert C Millikan, Beth Newman, Chiu-Kit Tse, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patientsLynn G Dressler, Donald A Berry, Gloria Broadwater, et al.The New England Journal of Medicine|October 12, 2007
HER2 and response to paclitaxel in node-positive breast cancerDaniel F Hayes, Ann D Thor, Lynn G Dressler, et al.Stem Cell Research|February 26, 2018
Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3Charline Jansch, Katharina Günther, Jonas Waider, et al.Pageof 32